REEDS_CorpTagline_Color_300.png
Reed’s Inc. Prices Underwritten Public Offering of Common Stock
February 15, 2019 08:16 ET | Reed's Inc.
NORWALK, Conn., Feb. 15, 2019 (GLOBE NEWSWIRE) -- Reed’s Inc. (NYSE American: REED), owner of the nation’s leading portfolio of handcrafted, all-natural beverages, today announced the pricing of an...
REEDS_CorpTagline_Color_300.png
Reed’s Inc. Announces Proposed Public Offering of Common Stock
February 14, 2019 16:05 ET | Reed's Inc.
NORWALK, Conn., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Reed’s Inc. (NYSE American: REED), owner of the nation’s leading portfolio of handcrafted, all-natural beverages, today announced that it intends to...
VBI-Vaccines-Vertical-Logo.png
VBI Vaccines Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriter’s Option to Purchase Additional Shares for Aggregate Gross Proceeds of $42.9 Million
December 18, 2018 08:00 ET | VBI Vaccines, Inc.
CAMBRIDGE, Mass., Dec. 18, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
S-2448-22FLP-1
Legacy Housing Corp. Announces Pricing of Initial Public Offering
December 14, 2018 09:48 ET | Legacy Housing Corporation
DALLAS, Dec. 14, 2018 (GLOBE NEWSWIRE) -- Legacy Housing Corporation (Nasdaq: LEGH), the fourth largest producer of manufactured homes in the United States and a recognized leader and innovator in...
VBI-Vaccines-Vertical-Logo.png
VBI Vaccines Announces Pricing of $37.5 Million Public Offering
December 13, 2018 09:05 ET | VBI Vaccines, Inc.
CAMBRIDGE, Mass., Dec. 13, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
VBI-Vaccines-Vertical-Logo.png
VBI Vaccines Announces Proposed Public Offering of Common Shares
December 12, 2018 16:01 ET | VBI Vaccines, Inc.
CAMBRIDGE, Mass., Dec. 12, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
InspireMD Logo.png
InspireMD, Inc. Announces Pricing of $10 Million Underwritten Public Offering
June 29, 2018 10:24 ET | InspireMD, Inc.
Tel Aviv, Israel, June 29, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,...
Cowen_Logo_rgb_k.jpg
Cowen Announces Closing of Underwriters’ Exercise of Over-Allotment Option to Purchase an Additional $10.0 Million of 7.75% Senior Notes Due 2033
June 18, 2018 16:01 ET | Cowen Inc.
NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- Cowen Inc. (NASDAQ:COWN) (the “Company”) announced today the underwriters for the recently completed public offering of the Company’s 7.75% senior notes...
Cowen_Logo_rgb_k.jpg
Cowen Inc. Announces Closing of Public Offering of 7.75% Senior Notes Due 2033
June 11, 2018 16:01 ET | Cowen Inc.
NEW YORK, June 11, 2018 (GLOBE NEWSWIRE) -- Cowen Inc. (NASDAQ:COWN) (the “Company”) announced today that its previously announced public offering of $90,000,000 million of 7.75% senior notes due...
Optinose_logo_RGB.png
Optinose Announces Launch of Public Offering of Common Stock
June 04, 2018 16:56 ET | OptiNose, Inc.
YARDLEY, Pa., June 04, 2018 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission...